¹æ»ç¼±¿ä¹ýÀ¸·Î Ä¡·áÇÑ ÀڱøñÀÇ Ä§À±¼º ÆíÆò¼¼Æ÷¾ÏÁ¾¿¡¼ HIF-1 ´Ü¹é ¹ßÇö
Expression of Hypoxia Inducible Factor-1 in Invasive Squamous Cell Carcinoma of Uterine Cervix Treated by Radiotherapy
ÀÌ°æÀÚ, À¯Àº¼±, ¹Ú¼ö¿¬, ¹ÚÇý¼÷, ¼Çö¼÷, ±è¼ºÃ¶, ½É±â³², Á¤¼º¾Ö, À¯±Ç, ¼º¼øÈñ, Á¶¹Î¼±, À̽ó», ¹ÚÇý¿µ, ¹®Çý¼º, ÀÌ°æÀº,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ°æÀÚ ( Lee Kyung-Ja )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç
À¯Àº¼± ( Yoo Eun-Sun )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
¹Ú¼ö¿¬ ( Park Soo-Yeun )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ÇغÎÇб³½Ç
¹ÚÇý¼÷ ( Park Hye-Sook )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
¼Çö¼÷ ( Suh Hyun-Suk )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç
±è¼ºÃ¶ ( Kim Seung-Cheol )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
½É±â³² ( Shim Ki-Nam )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¤¼º¾Ö ( Jung Sung-Ae )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
À¯±Ç ( Yoo Kwon )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¼º¼øÈñ ( Sung Sun-Hee )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¶¹Î¼± ( Cho Min-Sun )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
À̽ó» ( Lee Shi-Nae )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹ÚÇý¿µ ( Park Hae-Young )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈÇб³½Ç
¹®Çý¼º ( Moon Hye-Sung )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
ÀÌ°æÀº ( Lee Kyung-Eun )
ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
KMID : 0357920050390050307
Abstract
Background: Hypoxia-inducible factor-1 (HIF-1 ) is an intrinsic marker of tumor hypoxia, and this is associated with reduced radiosensitivity. Furthermore, HIF-1 can increase a tumor¢¥¢¥s aggressiveness by promoting neoangiogenesis, cell proliferation and survival, and invasion.
Methods: The expression of HIF-1 was was investigated by performing immunohistochemistry on the cervical tissue specimens obtained from 57 patients who had received radiotherapy combined with or without chemotherapy for stages I-III cervical squamous cell carcinoma. The staining results were compared with anemia, the stage, the radiotherapy response and patient survival by univariate and multivariate analysis.
Results: In 57 patients, the expression of HIF-1 was seen in the tissue specimens of 46 patients (81.7%). Among them, 25 (54.3%), 14 (30.4%), and 7 (15.2%) of the patients¢¥¢¥ tissue specimens showed weak, moderate and strong expressions, respectively. Six patients had a partial response after radiotherapy. Twelve patients (21.1%) died of cervical cancer. The increased expression of HIF-1 was significantly associated (p<0.05) with the disease stage and anemia. There were significant positive correlations between the increased expression of HIF-1 and the poor response after radiotherapy and the patients¢¥¢¥ survival.
Conclusions: The present result suggests that the overexpression of HIF-1 in the uterine cervix could be used as a prognostic indicator for the patients treated with radiotherapy.
Å°¿öµå
Cervix Neoplasms;Carcinoma; Squamous cell;Hypoxia Inducible Factor 1;Immunohistochemistry
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸